Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2036.2003.01695.xPMID 12969088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme

  2002cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• Therapy for Helicobacter pylori in Patients with Nonulcer Dyspepsia

  2001cited by this paper
• Helicobacter pylori and functional dyspepsia

  2001cited by this paper
• Recurrent symptoms and gastro‐oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection

  2000cited by this paper
• Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia

  2000cited by this paper
• Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

  2000cited by this paper
• High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis

  2000cited by this paper
• Eradication of Helicobacter pylori and non-ulcer dyspepsia.

  2000cited by this paper
• Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

  1999cited by this paper
• Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting

  1999cited by this paper
• Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

  1999cited by this paper
• Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia.

  1999cited by this paper
• Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up

  1999cited by this paper
• Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.

  1999cited by this paper
• US transplant system.

  1998cited by this paper
• Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

  1998cited by this paper
• Patient recruitment in Helicobacter pylori drug trials.

  1998cited by this paper
• Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

  1998cited by this paper
• Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia.

  1998cited by this paper
• Classification and Grading of Gastritis: The Updated Sydney System

  1997cited by this paper
• Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia.

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

  1997cited by this paper
• Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.

  1997cited by this paper
• The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.

  1997cited by this paper
• Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

  1996cited by this paper
• Review article: symptom improvement through eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia

  1996cited by this paper
• Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.

  1994cited by this paper
• A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

  1994cited by this paper
• THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

  1934cited by this paper
• LACK OF EFFECT OF TREATING H. PYLORI INFECTION IN PATIENTS WITH NONULCER DYSPEPSIA LACK OF EFFECT OF TREATING HELICOBACTER PYLORI INFECTION IN PATIENTS WITH NONULCER DYSPEPSIA

  year unknowncited by this paper

• Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II

  2025cites this paper
• Factors Predicting Effectiveness of Eradication Therapy for Helicobacter pylori-Associated Dyspepsia Symptoms

  2024cites this paper
• Population based treatment strategy of H pylori in Qatar: Through clinical and demographic insights.

  2024cites this paper
• Helicobacter pylori Diagnosis and Treatment in Africa: The First Lagos Consensus Statement of the African Helicobacter and Microbiota Study Group

  2024cites this paper
• Helicobacter pylori infection

  2023cites this paper
• Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial

  2023cites this paper
• Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

  2023cites this paper
• Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

  2022cites this paper
• Altered Vagal Signaling and Its Pathophysiological Roles in Functional Dyspepsia

  2022cites this paper
• Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis

  2022cites this paper
• Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders

  2022cites this paper
• Analyzing Changing Primary Treatment Pattern Trends for Helicobacter pylori Infection Using a Common Data Model

  2022cites this paper
• The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology

  2021cites this paper
• Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020

  2021cites this paper
• Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020

  2021cites this paper
• Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition

  2020cites this paper
• Clinical Practice Guidelines for Functional Dyspepsia in Korea

  2020cites this paper
• [Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori].

  2019cites this paper
• Helicobacter pylori Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and H. pylori Prevalence

  2019cites this paper
• Review article: treatment options for functional dyspepsia

  2019cites this paper
• Changes of Dyspeptic Symptom after Successful Eradication in Helicobacter pylori-Associated Dyspepsia

  2019cites this paper
• Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit.

  2019cites this paper
• Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay

  2019cites this paper
• Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study

  2018cites this paper
• Helicobacter Pylori Infection.

  2018cites this paper
• Helicobacter pylori management in ASEAN: The Bangkok consensus report

  2018cites this paper
• Management of Helicobacter pylori Infection.

  2017cites this paper
• Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action.

  2017cites this paper
• Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone

  2017cites this paper
• Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China.

  2017cites this paper
• Prevalence of Helicobacter Pylori Infection and Stress, Anxiety or Depression in Functional Dyspepsia and Outcome after Appropriate Intervention.

  2017cites this paper
• High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.

  2016cites this paper
• Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.

  2016cites this paper
• Kyoto global consensus report on Helicobacter pylori gastritis

  2015cites this paper
• Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

  2015cites this paper
• Systematic review with meta‐analysis: post‐infectious functional dyspepsia

  2015cites this paper
• Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies.

  2015cites this paper
• Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease

  2014cites this paper
• Helicobacter pylori infection

  2013cites this paper
• Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.

  2011cites this paper
• Helicobacter pylori eradication in functional dyspepsia: HEROES trial.

  2011cites this paper
• Should We Still Subcategorize Helicobacter pylori-Associated Dyspepsia as Functional Disease?

  2011cites this paper
• A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals

  2011cites this paper
• Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia".

  2011cites this paper
• Helicobacter pylori eradication – Author's reply

  2011cites this paper
• Helicobacter pylori Eradication in Functional Dyspepsia

  2011cites this paper
• , a novel P-CAB

  2010cites this paper
• monofumarate (TAK-438), A Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases. Authors

  2010cites this paper
• 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases

  2010cites this paper
• Upper gastrointestinal disorders: symptom generation and proton pump inhibitor use

  2010cites this paper
• Role of Helicobacter pylori infection on neuronal expression in the stomach and spinal cord of a murine model

  2009cites this paper
• S3-Leitlinie

  2009cites this paper
• Helicobacter pylori

  2009cites this paper
• Helicobacter pylori and gastroduodenal ulcer disease.

  2009cites this paper
• S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2009cites this paper
• S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e. V.

  2009cites this paper
• Kurzfassung der S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten

  2009cites this paper
• Gastric motility: Measurement, symptoms and therapy

  2008cites this paper
• Factors involved in the regulation of gastrointestinal motility, hormone release, symptoms and energy intake in health and patients with functional dyspepsia.

  2008cites this paper
• Symptoms, endoscopic findings and histology predicting symptomatic benefit of Helicobacter pylori eradication

  2008cites this paper
• Measurement, symptoms and therapy

  2008cites this paper
• Treatment of Helicobacter pylori infection in functional dyspepsia

  2008cites this paper
• KAPITEL B6 – Ösophagus und Magen

  2008cites this paper
• Magen-Darm-Mittel und Laxantien

  2008cites this paper
• Helikobakter pilori (+) fonksiyonel dispepside 7 ve 14 günlük pantoprazol temelli üçlü kombinasyon tedavisinin eradikasyona ve eradikasyonun semptomlara olan etkinliğinin değerlendirilmesi

  2008cites this paper
• Estudo de custo-utilidade das alternativas de abordagem da dispepsia não investigada em países de alta prevalência do Helicobacter pylori

  2008cites this paper
• WHAT ARE THE AREAS OF CONTROVERSY FOR WHICH THERE MIGHT BE BENEFIT OF ERADICATING H . PYLORI INFECTION ?

  2007cites this paper
• STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study

  2007cites this paper
• American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection

  2007cites this paper
• Treatment of H. pylori infection: Current recommendations

  2007cites this paper
• Motility and Functional Disorders of the Stomach: Diagnosis and Management of Functional Dyspepsia and Gastroparesis

  2006cites this paper
• Clinical Outcomes of Eradication of Helicobacter pylori in Nonulcer Dyspepsia in a Population with a High Prevalence of Infection: Results of a 12-Month Randomized, Double Blind, Placebo-Controlled Study

  2006cites this paper
• Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study

  2006cites this paper
• Proposal for Slovenian recommendations for the treatment of patients with dyspepsia

  2006cites this paper
• The effect of Helicobacter pylori eradication on the improvement of the symptoms in patients with functional dyspepsia and peptic ulcer disease

  2006cites this paper
• Drug treatment of functional dyspepsia.

  2006cites this paper
• Review article: current and emerging therapies for functional dyspepsia

  2006cites this paper
• Nonulcer dyspepsia and Helicobacter pylori eradication in children.

  2005cites this paper
• Functional dyspepsia pathogenesis and therapeutic options--implications for management.

  2005cites this paper
• Efecto del tratamiento erradicador en pacientes con dispepsia funcional e infección por Helicobacter pylori: ensayo clínico aleatorizado frente a placebo

  2005cites this paper
• Therapie der Helicobacter-pylori- Infektion

  2005cites this paper
• What is new related to Helicobacter pylori infection in children and teenagers?

  2005cites this paper
• merican Gastroenterological Association Technical Review on he Evaluation of Dyspepsia his literature review and the recommendations

  2005cites this paper
• Review article: Helicobacter pylori and gastro‐oesophageal reflux disease

  2005cites this paper
• Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator‐blinded, placebo‐controlled trial

  2005cites this paper
• Different aspects in functional dyspepsia.

  2005cites this paper
• [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].

  2005cites this paper
• American gastroenterological association technical review on the evaluation of dyspepsia.

  2005cites this paper
• Eradication of Helicobacter pylori: a clinical update.

  2004cites this paper
• Delta values of the 13 C-urea breath test in Helicobacter pylori positive persons with and without dyspepsia 105

  2004cites this paper
• Uninvestigated dyspepsia and non‐ulcer dyspepsia—the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy

  2004cites this paper
• Helicobacter pylori and Nonmalignant Diseases

  2004cites this paper
• Index

  2003cites this paper
• Helicobacter pylori and nonmalignant diseases

  2002cites this paper